The corporation aims to increase its expenditure in biotechnology and biosimilars, targeting an approximate sector price of USD 25 billion in India by 2025. Wockhardt's efforts to scale up production capabilities are evident, with designs to boost output potential by 30% more than the next two yrs. Promethazine hydrochloride tablets https://throbsocial.com/story21974769/the-definitive-guide-to-codeine